eXciteOSA® First Daytime Therapy for Mild Sleep Apnea and Primary Snoring
One of our flagship technologies, eXciteOSA® exemplifies our commitment to excellence. FDA-authorized and rapidly gaining recognition, eXciteOSA® is emerging as the leading solution for mild obstructive sleep apnea (OSA). As a first-line therapy, eXciteOSA® will give better patient outcomes and save billions of dollars in healthcare costs associated with sleep disordered breathing and displace a significant portion of costly, cumbersome CPAP machines. With growing support from CMS, Medicare, Medicaid, and private insurers, eXciteOSA is transforming sleep related patient care.
OUR VISION
Founded by a team of visionary leaders from healthcare, business, finance, and regulatory sectors, MedSelect is committed to integrating the latest medical advancements with global best practices. Our mission is to ensure alignment with FDA, federal, and state regulations, delivering top-tier medical technologies to healthcare providers.
MEDICAL INNOVATION
MedSelect is revolutionizing the healthcare market by introducing cutting-edge medical technologies from around the globe. We specialize in bringing innovative medical solutions to the forefront of the industry. With wellness as our motto, we are committed to improving the health and well-being of our community.
PARTNER WITH US
As a master licensor of groundbreaking medical technologies, MedSelect is actively seeking distribution partners. Join us in bringing eXciteOSA® and other life-changing innovations to market.